EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Updates on intranasal nanomedicine design for central nervous system disease treatment

Rui Yang, Zhengwei Huang, Xuejuan Zhang

Exploration of Drug Science · 10.03.2026 · 4

DOI: 10.37349/eds.2026.1008154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Drug Science, online erschienen am 10.03.2026. Verfasst von Rui Yang und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intranasal drug delivery exhibits therapeutic potential for the treatment of central nervous system (CNS) diseases, as it allows pharmaceuticals to bypass the blood-brain barrier (BBB) via the olfactory and trigeminal pathways. The primary advantage of this method lies in its non-invasiveness and low systemic toxicity. Nevertheless, this delivery method faces notable challenges, including limited nasal mucosal absorption and short residence time in the olfactory region. To address these limitations, intranasal nanomedicine has gained research attention. Nanomedicines can improve brain bioavailability by enhancing drug solubility, permeability, and stability. The following discussion summarizes recent advancements in nanotechnology-enabled nose-to-brain delivery systems, with the aim of synthesizing progress in the field and outlining future research directions.

Zitieren

APA

Yang, R., Huang, Z., & Zhang, X. (2026). Updates on intranasal nanomedicine design for central nervous system disease treatment. Exploration of Drug Science, 4. https://doi.org/10.37349/eds.2026.1008154

Vancouver

Yang R, Huang Z, Zhang X. Updates on intranasal nanomedicine design for central nervous system disease treatment. Exploration of Drug Science. 2026;4. doi:10.37349/eds.2026.1008154

BibTeX
@article{Yang2026,
  author = {Yang, Rui and Huang, Zhengwei and Zhang, Xuejuan},
  title = {Updates on intranasal nanomedicine design for central nervous system disease treatment},
  journal = {Exploration of Drug Science},
  year = {2026},
  volume = {4},
  doi = {10.37349/eds.2026.1008154}
}
Kostenlos starten →